» Articles » PMID: 32915897

Improved Glycaemic Variability and Basal Insulin Dose Reduction During a Running Competition in Recreationally Active Adults with Type 1 Diabetes-A Single-centre, Prospective, Controlled Observational Study

Abstract

Introduction: To investigate the glycaemic response, macronutrient intake and insulin management in people with type 1 diabetes (T1D) compared to healthy individuals around a running competition.

Material And Methods: This was a single-centre, prospective, controlled observational study performed in individuals with T1D and healthy people. 24 people (12 T1D) were included in this study (age: T1D 41±12 vs. healthy 38±6 years, females: 3 vs. 6, BMI: 25.53.0 vs. 22.9±2.8 kg/m2). Both groups received an intermittently scanned continuous glucose monitoring (isCGM; FreeStyle Libre 1, Abbott, USA) system to assess glycaemia 24 hours before, during and 24 hours after a running competition. During this period, participants recorded their food intake and insulin administration. Data were analysed via ANOVA and mixed model analyses with post-hoc testing (p≤0.05).

Results: For overall glycaemic ranges in comparison of groups, significant differences were found for time in range (T1D 63±21% vs. healthy 89±13%, p = 0.001), time above range (TAR) 1 (T1D 21±15% vs. healthy 0±0%, p<0.001) and TAR 2 (T1D 8 [0-16%] vs. healthy 0±0%, p<0.001). When glycaemic variability was assessed, people with T1D had a higher glycaemic variability compared to healthy individuals (p<0.0001). Basal insulin dose was significantly reduced when compared against the regular pre-study basal insulin dose (pre-study 22±6 vs. pre-competition day 11±9 (-50±41%), p = 0.02; competition day 15±5 (-32± 1%)).

Conclusion: People with T1D have impaired glucose responses around a running competition compared to healthy individuals. However, basal insulin dose reductions were sufficient to prevent further dysglycaemia.

Clinical Trial Id: drks.de; DRKS00019886.

Citing Articles

Dynamic of Glucose Homeostasis in Virtual Patients: A Comparison between Different Behaviors.

Alonso-Bastida A, Adam-Medina M, Posada-Gomez R, Salazar-Pina D, Osorio-Gordillo G, Vela-Valdes L Int J Environ Res Public Health. 2022; 19(2).

PMID: 35055537 PMC: 8775377. DOI: 10.3390/ijerph19020716.


Comparing Two Treatment Approaches for Patients with Type 1 Diabetes During Aerobic Exercise: a Randomised, Crossover Study.

Vartak V, Chepulis L, Driller M, Paul R Sports Med Open. 2021; 7(1):29.

PMID: 33914197 PMC: 8085176. DOI: 10.1186/s40798-021-00319-5.


Bolus insulin dose depends on previous-day race intensity during 5 days of professional road-cycle racing in athletes with type 1 diabetes: A prospective observational study.

Moser O, Dietrich M, McCarthy O, Bracken R, Eckstein M Diabetes Obes Metab. 2020; 22(10):1714-1721.

PMID: 32383791 PMC: 7540083. DOI: 10.1111/dom.14083.

References
1.
Maran A, Pavan P, Bonsembiante B, Brugin E, Ermolao A, Avogaro A . Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes. Diabetes Technol Ther. 2010; 12(10):763-8. DOI: 10.1089/dia.2010.0038. View

2.
Plotnikoff R, Taylor L, Wilson P, Courneya K, Sigal R, Birkett N . Factors associated with physical activity in Canadian adults with diabetes. Med Sci Sports Exerc. 2006; 38(8):1526-34. DOI: 10.1249/01.mss.0000228937.86539.95. View

3.
Scheen A, Buxton O, Jison M, Van Reeth O, Leproult R, LHermite-Baleriaux M . Effects of exercise on neuroendocrine secretions and glucose regulation at different times of day. Am J Physiol. 1998; 274(6):E1040-9. DOI: 10.1152/ajpendo.1998.274.6.E1040. View

4.
Brazeau A, Leroux C, Mircescu H, Rabasa-Lhoret R . Physical activity level and body composition among adults with type 1 diabetes. Diabet Med. 2012; 29(11):e402-8. DOI: 10.1111/j.1464-5491.2012.03757.x. View

5.
Tikkanen-Dolenc H, Waden J, Forsblom C, Harjutsalo V, Thorn L, Saraheimo M . Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease. Diabetes Care. 2017; 40(12):1727-1732. DOI: 10.2337/dc17-0615. View